Cargando...
Understanding the In Vivo Fate of Radioimmunoconjugates for PET and SPECT
Over the past 25 years, antibodies have emerged as extraordinarily promising vectors for the delivery of radionuclides to tumors for nuclear imaging. While radioimmunoconjugates often produce very high activity concentrations in target tissues, they also are frequently characterized by elevated acti...
Gardado en:
| Publicado en: | J Labelled Comp Radiopharm |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6432633/ https://ncbi.nlm.nih.gov/pubmed/29665104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jlcr.3628 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|